Artículo

Buenos Aires cohort of men who have sex with men: Prevalence, incidence, risk factors, and molecular genotyping of HIV type 1

Segura, Marcela ; Sosa-Estani, Sergio Alejandro Icon; Marone, Rubén ; Bautista, Christian T. ; Pando, María de los Ángeles Icon; Eyzaguirre, Lindsay ; Sánchez, José L. ; Carr, Jean K. ; Montano, Silvia M. ; Weissenbacher, Mercedes Crecencia Icon; Avila, Maria Mercedes Icon

Otros responsables

Fecha

12/2007

Editorial

Mary Ann Liebert

Revista

Aids Research and Human Retroviruses

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0889-2229

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Palabras clave

Resumen

The prevalence, incidence, risk factors, and molecular genotyping of HIV-1 infection among men who have sex with men (MSM) were assessed through a prospective cohort study. The study was conducted in Buenos Aires from February 2003 to December 2004. Sociodemographic, sexual risk behavior data, and blood samples for HIV testing were collected at baseline and at 6 and 12 months. Cox regression analysis was applied to determine risk factors associated with HIV seroconversion. HIV-positive samples were analyzed by partial (pro/RT) and full-length genome sequencing. Of 811 HIV-negative participants evaluated at baseline, 327 volunteers that fulfilled the inclusion criteria were enrolled. Retention rates at 6 and 12 months were 97.2% and 91.5%, respectively. Twelve MSM seroconverted for HIV infection [incidence rate = 3.9 (95% CI = 2.0-6.7) per 100 person-years]. HIV seroconversion was associated with a greater number of different sexual contacts in the preceding 6 months (≥10, hazard ratio = 3.3, 95% CI: 1.1-10.4). By partial pro/RT genotyping analysis, 83% HIV-positive samples were subtype B and 17% samples were BF recombinants, most of these being unique recombinant forms. This study describes for the first time the recruitment and follow-up of a cohort of MSM in Argentina. Retention rates and HIV incidence rate were high. These data should be considered as a promising potential population for HIV vaccine trials.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa